miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. Thor A, Myklebust MP, Bergdahl AG, Lundgren PO, et al. J Urol 2024 Jul 25:101097JU0000000000004164. doi: 10.1097/JU.0000000000004164.

Read + Share

Amedeo Smart

Independent Medical Education

Thor A, Myklebust MP, Bergdahl AG, Lundgren PO, et al. miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. J Urol 2024 Jul 25:101097JU0000000000004164. doi: 10.1097/JU.0000000000004164.
PMID: 39052680